Effectiveness of antiemetic triplet therapy with aprepitant, palonosetron, and dexamethasone for gynecologic cancer patients receiving carboplatin and paclitaxel: a prospective single-arm study

被引:0
|
作者
Fuminori Ito
Naoto Furukawa
机构
[1] Nara Medical University,Department of Obstetrics and Gynecology
[2] Nara Prefecture Western Medical Center,Department of Obstetrics and Gynecology
来源
Supportive Care in Cancer | 2017年 / 25卷
关键词
Chemotherapy-induced nausea and vomiting; Paclitaxel and carboplatin; Aprepitant; Palonosetron;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1941 / 1945
页数:4
相关论文
共 50 条
  • [1] Effectiveness of antiemetic triplet therapy with aprepitant, palonosetron, and dexamethasone for gynecologic cancer patients receiving carboplatin and paclitaxel: a prospective single-arm study
    Ito, Fuminori
    Furukawa, Naoto
    SUPPORTIVE CARE IN CANCER, 2017, 25 (06) : 1941 - 1945
  • [2] Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy
    Koshiyama, Masafumi
    Matsumura, Noriomi
    Imai, Saeko
    Yamanoi, Koji
    Abiko, Kaoru
    Yoshioka, Yumiko
    Yamaguchi, Ken
    Hamanishi, Junzo
    Baba, Tsukasa
    Konishi, Ikuo
    MEDICAL SCIENCE MONITOR, 2017, 23 : 826 - 833
  • [3] Comparison of the antiemetic effect of aprepitant/granisetron and palonosetron combined with dexamethasone in gynecological cancer patients treated with paclitaxel and carboplatin combination regimen
    OBAYASHI, K.
    NAGAMINE, A.
    YASHIMA, H.
    OHSHIMA, S.
    UCHIYAMA, C.
    TAKAHASHI, E.
    TAKAHASHI, Y.
    ARAKI, T.
    YAMAMOTO, K.
    PHARMAZIE, 2022, 77 (05): : 157 - 161
  • [4] EFFICACY OF TRIPLET ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: PALONOSETRON, APREPITANT, AND DEXAMETHASONE
    Hayashi, M.
    Miura, S.
    Sato, K.
    Makino, M.
    Kobayashi, O.
    Miyao, H.
    Iwashima, A.
    Ichikawa, K.
    Koshio, J.
    Watanabe, S.
    Tanaka, J.
    Kagamu, H.
    Yokoyama, A.
    Narita, I.
    Yoshizawa, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 88 - 88
  • [5] Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy
    Takeshi Kitazaki
    Yuichi Fukuda
    Susumu Fukahori
    Kazuhiko Oyanagi
    Hiroshi Soda
    Yoichi Nakamura
    Shigeru Kohno
    Supportive Care in Cancer, 2015, 23 : 185 - 190
  • [6] Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy
    Kitazaki, Takeshi
    Fukuda, Yuichi
    Fukahori, Susumu
    Oyanagi, Kazuhiko
    Soda, Hiroshi
    Nakamura, Yoichi
    Kohno, Shigeru
    SUPPORTIVE CARE IN CANCER, 2015, 23 (01) : 185 - 190
  • [7] THE EFFICACY OF TRIPLET ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: PALONOSETRON (PALO), APREPITANT (APR), AND DEXAMETHASONE (DEX)
    Yoshizawa, H.
    Sato, K.
    Makino, M.
    Kobayashi, O.
    Tanaka, H.
    Miura, S.
    Watanabe, S.
    Tanaka, J.
    Kagamu, H.
    Ichiei, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 509 - 509
  • [8] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
    Miya, Toshimichi
    Kobayashi, Kunihiko
    Hino, Mitsunori
    Ando, Masahiro
    Takeuchi, Susumu
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    SPRINGERPLUS, 2016, 5
  • [9] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy.
    Miya, Toshimichi
    Kobayashi, Kunihiko
    Hino, Mitsunori
    Ando, Masahiro
    Takeuchi, Susumu
    Seike, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [10] Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study
    Murat Araz
    Mustafa Karaagac
    Levent Korkmaz
    Lokman Koral
    Fatih Inci
    Ismail Beypinar
    Mukremin Uysal
    Mehmet Artac
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 1091 - 1097